BOLD - Audentes Therapeutics Inc. (BOLD) CEO Matt Patterson on Q2 2019 Results - Earnings Call Transcript
Audentes Therapeutics, Inc. (BOLD)
Q2 2019 Earnings Conference Call
August 06, 2019 04:30 PM ET
Company Participants
Andrew Chang - Head, IR
Matt Patterson - Chairman and Chief Executive Officer
Natalie Holles - President and Chief Operating Officer
Tom Soloway - Executive Vice President and Chief Financial Officer
Conference Call Participants
Anupam Rama - JP Morgan
Nicole Gabreski - Piper Jaffray
Dae Ha - SVB Leerink
Ritu Baral - Cowen
Whitney Ijem - Guggenheim
Steve Seedhouse - Raymond James
Debjit Chattopadhyay - H.C. Wainwright
Rajiv Prasad - William Blair
Matthew Luchini - BMO Capital Market